To explore the detailed mechanisms that mediate the activation of CD8+ T cells, we analyzed the drug combinations treated tumor tissues and found tumor microenvironment was reshaped through CCL5 mediated CD8+ T cell recruitment. Here, CD8A is linked to neoplasm.